Gepotidacin and nitrofurantoin demonstrate similar efficacy in reducing symptom severity and restoring daily function in women with uncomplicated UTI.

Vaccine-induced protection against HPV-related genital disease may be strong among men, supporting its role in equitable and gender-neutral control of HPV disease.

Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

Clinical outcomes were similar across different viral ARIs among inpatients with hematologic malignancy or HSCTs.

A growing number of states are rolling back financial help for HIV medications, according to a recent analysis.

An expected review of the United States’ measles elimination status has been postponed by 7 months from April to November.

Supervised HIIT and CME combined with resistance training significantly improved physical function in older patients with HIV.

The US Consumer Product Safety Commission recalled about 81,000 babysense Max View Baby Monitors because the display unit can overheat.

Cirrhosis, malignancy, and acute kidney injury are among the clinical factors associated with early mortality in patients with septic shock.

In a major shift, the US Food and Drug Administration is relaxing a long-standing drug approval requirement for common diseases.

CDC data show SARS-CoV-2 and RSV continue to impact younger children and older adults, with significant hospitalization and mortality rates across the US.

The AAP 2026 schedule maintains status for vaccines the CDC moved to shared clinical decision-making, aiming to avoid clinician and parent confusion.